Able to speak English Language
Item
english speakers
boolean
C0564215 (UMLS CUI [1,1])
C0376245 (UMLS CUI [1,2])
Multiple Sclerosis, Relapsing-Remitting
Item
relapsing-remitting ms (2010 criteria)
boolean
C0751967 (UMLS CUI [1])
EDSS
Item
expanded disability status scale (edss) ≤6.0
boolean
C0451246 (UMLS CUI [1])
Availability of Smartphone | Availability of Mobile Phone | Availability of Text Messaging | Availability of Email | Internet Access
Item
possession of a smartphone or of a mobile telephone with text messaging and an e-mail account and web access or willingness to be provided with, and utilize, a smartphone for the duration of the study
boolean
C0470187 (UMLS CUI [1,1])
C3204335 (UMLS CUI [1,2])
C0470187 (UMLS CUI [2,1])
C1136360 (UMLS CUI [2,2])
C0470187 (UMLS CUI [3,1])
C3178908 (UMLS CUI [3,2])
C0470187 (UMLS CUI [4,1])
C0013849 (UMLS CUI [4,2])
C0282111 (UMLS CUI [5,1])
C0444454 (UMLS CUI [5,2])
Status pre- Screening
Item
in the two years before screening:
boolean
C0332152 (UMLS CUI [1,1])
C0220908 (UMLS CUI [1,2])
Relapse Quantity | Lesion New Quantity MRI | Relapsing-Remitting Multiple Sclerosis Past Year | Disease Modification Therapy Absent
Item
at least two relapses, or one relapse and two new lesions (unrelated to relapse symptoms) on magnetic resonance imaging (mri), or rrms (magnims 2010 criteria) onset within the past year with no exposure to disease modifying therapies (dmt)
boolean
C0035020 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0221198 (UMLS CUI [2,1])
C0205314 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
C0024485 (UMLS CUI [2,4])
C0751967 (UMLS CUI [3,1])
C4086728 (UMLS CUI [3,2])
C0012634 (UMLS CUI [4,1])
C3840684 (UMLS CUI [4,2])
C0087111 (UMLS CUI [4,3])
C0332197 (UMLS CUI [4,4])
Therapy Multiple Sclerosis | Therapy Injectable | Interferon-beta Subcutaneous | Glatiramer acetate Subcutaneous | Therapy Oral | fingolimod | teriflunomide | dimethyl fumarate
Item
patient is starting one of the following ms therapies: injectable (subcutaneous interferon beta or glatiramer acetate) or oral (fingolimod, teriflunomide, or dimethyl fumarate) therapies
boolean
C0087111 (UMLS CUI [1,1])
C0026769 (UMLS CUI [1,2])
C0087111 (UMLS CUI [2,1])
C1828121 (UMLS CUI [2,2])
C0015980 (UMLS CUI [3,1])
C1522438 (UMLS CUI [3,2])
C0289884 (UMLS CUI [4,1])
C1522438 (UMLS CUI [4,2])
C0087111 (UMLS CUI [5,1])
C1527415 (UMLS CUI [5,2])
C1699926 (UMLS CUI [6])
C1718383 (UMLS CUI [7])
C0058218 (UMLS CUI [8])
Relapse | MRI | Therapy Absent | Therapy Single | Therapy unchanged
Item
relapse and mri activity occurred while untreated or despite one single treatment, and no change in therapy since that activity
boolean
C0035020 (UMLS CUI [1])
C0024485 (UMLS CUI [2])
C0087111 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C0087111 (UMLS CUI [4,1])
C0205171 (UMLS CUI [4,2])
C0087111 (UMLS CUI [5,1])
C0442739 (UMLS CUI [5,2])
Residence Geographic region Nearby
Item
lives within 100 miles of johns hopkins medical center (baltimore, md)
boolean
C0237096 (UMLS CUI [1,1])
C0017446 (UMLS CUI [1,2])
C1706276 (UMLS CUI [1,3])
Disease Modification Therapy | Therapy changed Multiple Sclerosis
Item
history of dmt exposure if magnims 2010 criteria used to enroll patients with disease onset in the past year, or change in ms therapy since qualifying relapse/mri criteria occurred
boolean
C0012634 (UMLS CUI [1,1])
C3840684 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,3])
C1141862 (UMLS CUI [2,1])
C0026769 (UMLS CUI [2,2])